Loading viewer...
investor_presentation
Format: PDF investor_presentation
Jacobs presented its financial outlook and corporate strategy in August 2024, discussing fiscal year 2024 performance metrics including adjusted EBITDA, adjusted EPS, and free cash flow conversion. The presentation addresses the proposed Separation Transaction to spin off and merge the Separated Businesses with Amentum, along with strategic initiatives and non-GAAP reconciliations.
investor_presentation
26 Pages
investor_presentation
33 Pages
Thorne HealthTech
POINT Biopharma Investor Presentation September 2023
investor_presentationinvestor_presentation
58 Pages
POINT Biopharma Global Inc.
